Survival in familial and non-familial breast cancer by age and stage at diagnosis

European Journal of Cancer

Volumn 52, Issue , 2016, Pages 10-18

  Kharazmi, Elham ^a   Försti, Asta ^a,b   Sundquist, Kristina ^b,c   Hemminki, Kari ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Familial risk; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FAMILIAL CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDE (PEOPLE); VERY ELDERLY; ADOLESCENT; AGE; BREAST NEOPLASMS; CHILD; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; HEREDITY; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PATHOLOGY; PEDIGREE; PHENOTYPE; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SWEDEN; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NEOPLASM STAGING; PEDIGREE; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84948406634     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.09.015     Document Type: Article

References (25)

1. C.T. Brekelmans, M.M. Tilanus-Linthorst, C. Seynaeve, A. vd Ouweland, M.B. Menke-Pluymers, C.C. Bartels, and et al. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 5 2007 867 876
2. D.G. Evans, and F. Lalloo Risk assessment and management of high risk familial breast cancer J Med Genet 39 12 2002 865 871
3. E. Kharazmi, M. Fallah, K. Sundquist, and K. Hemminki Familial risk of early and late onset cancer: nationwide prospective cohort study BMJ 345 2012 e8076
4. K. Hemminki, J. Sundquist, and A. Brandt Familial mortality and familial incidence in cancer J Clin Oncol 29 6 2011 712 718
5. I. Gavrilov, M. Nacheva, and D. Tzingilev Familial breast cancer. Part IV: survival of familial breast cancer in Bulgarian patients J BUON 8 4 2003 351 356
6. S. Margolin, H. Johansson, L.E. Rutqvist, A. Lindblom, and T. Fornander Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County Fam Cancer 5 4 2006 309 321
7. A. Brandt, J.L. Bermejo, J. Sundquist, and K. Hemminki Age of onset in familial breast cancer as background data for medical surveillance Br J Cancer 102 1 2009 42 47
8. K. Hemminki, J. Ji, A. Forsti, J. Sundquist, and P. Lenner Survival in breast cancer is familial Breast Cancer Res Treat 110 1 2008 177 182
9. L.S. Lindstrom, P. Hall, M. Hartman, F. Wiklund, H. Gronberg, and K. Czene Familial concordance in cancer survival: a Swedish population-based study Lancet Oncol 8 11 2007 1001 1006
10. E.H. Lee, S.K. Park, B. Park, S.W. Kim, M.H. Lee, S.H. Ahn, and et al. Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis Breast Cancer Res Treat 122 1 2010 11 25
11. G. Rennert, S. Bisland-Naggan, O. Barnett-Griness, N. Bar-Joseph, S. Zhang, H.S. Rennert, and et al. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 2 2007 115 123
12. K. Hemminki, X. Li, K. Plna, C. Granstrom, and P. Vaittinen The nation-wide Swedish family-cancer database-updated structure and familial rates Acta Oncol 40 6 2001 772 777
13. The National Board of Health and Welfare CfE Cancer incidence in Sweden 2006 2007
14. A. Brandt, J. Sundquist, and K. Hemminki Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer Ann Oncol 23 1 2012 251 256
15. A. Brandt, J. Sundquist, and K. Hemminki Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer Br J Dermatol 165 2 2011 342 348
16. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 2003 1625 1638
17. M.J. Hayat, N. Howlader, M.E. Reichman, and B.K. Edwards Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program Oncologist 12 1 2007 20 37
18. Society AC Breast cancer facts & figures Atlanta 2011-2012 American Cancer Society, Inc
19. C.K. Anders, D.S. Hsu, G. Broadwater, C.R. Acharya, J.A. Foekens, Y. Zhang, and et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 20 2008 3324 3330
20. J. Peppercorn Breast cancer in women under 40 Oncology (Williston Park) 23 6 2009 465 474
21. M.C. Hartley, B.P. McKinley, E.A. Rogers, C.A. Kalbaugh, H.S. Messich, D.W. Blackhurst, and et al. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study Am Surg 72 12 2006 1189 1194 discussion 1194-5
22. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease Lancet 358 9291 2001 1389 1399
23. A.J. van den Broek, M.K. Schmidt, L.J. van 't Veer, R.A. Tollenaar, and F.E. van Leeuwen Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis PLoS One 10 3 2015 e0120189
24. E.M. Azzato, J. Tyrer, P.A. Fasching, M.W. Beckmann, A.B. Ekici, R. Schulz-Wendtland, and et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival J Natl Cancer Inst 102 9 2010 650 662
25. R. Fagerholm, B. Hofstetter, J. Tommiska, K. Aaltonen, R. Vrtel, K. Syrjakoski, and et al. NAD(P)H:quinone oxidoreductase 1 NQO1∗2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer Nat Genet 40 7 2008 844 853